Diabetes Mellitus  >>  Soliris (eculizumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
NCT02727608: Complement Inhibitor Eculizumab in Clinical Islet Transplantation

Completed
2
3
Europe
Eculizumab, Soliris
Uppsala University
Diabetes Mellitus
05/18
06/18

Download Options